Sedative-analgesic combination

This page covers all Sedative-analgesic combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-2 adrenergic receptor; NMDA receptor.

Targets

Alpha-2 adrenergic receptor; NMDA receptor

Marketed (2)

• Dexmedetomidine-esketamine combination · Peking University First Hospital · Anesthesia / Sedation
  This combination pairs dexmedetomidine (an alpha-2 adrenergic agonist) with esketamine (an NMDA receptor antagonist) to produce sedation and analgesia with dissociative properties.
• Combined dexmedetomidine-esketamine · Peking University First Hospital · Anesthesia
  This combination drug pairs dexmedetomidine (an alpha-2 adrenergic agonist) with esketamine (an NMDA receptor antagonist) to produce sedation and analgesia with dissociative properties.